CN Patent

CN106999485B — 抗肺鳞癌的喹啉衍生物

Assigned to Chia Tai Tianqing Pharmaceutical Group Co Ltd · Expires 2020-04-14 · 6y expired

What this patent protects

本申请提供了一种抗肺鳞癌的喹啉衍生物。本申请所提供的1‑[[[4‑(4‑氟‑2‑甲基‑1H‑吲哚‑5‑基)氧基‑6‑甲氧基喹啉‑7‑基]氧基]甲基]环丙胺或其药学上可接受的盐可以用于治疗肺鳞癌，且相对于安慰剂，能显著延长肺鳞癌患者的无进展生存期。

USPTO Abstract

本申请提供了一种抗肺鳞癌的喹啉衍生物。本申请所提供的1‑[[[4‑(4‑氟‑2‑甲基‑1H‑吲哚‑5‑基)氧基‑6‑甲氧基喹啉‑7‑基]氧基]甲基]环丙胺或其药学上可接受的盐可以用于治疗肺鳞癌，且相对于安慰剂，能显著延长肺鳞癌患者的无进展生存期。

Drugs covered by this patent

Patent Metadata

Patent number
CN106999485B
Jurisdiction
CN
Classification
—
Expires
2020-04-14
Drug substance claim
No
Drug product claim
No
Assignee
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.